Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arsenic | 2 | 2024 | 144 | 1.380 |
Why?
|
Wound Healing | 5 | 2024 | 70 | 1.350 |
Why?
|
Skin | 3 | 2020 | 174 | 1.200 |
Why?
|
Fibroblasts | 6 | 2024 | 272 | 1.020 |
Why?
|
Tissue Scaffolds | 3 | 2020 | 25 | 0.900 |
Why?
|
Arsenicals | 1 | 2024 | 85 | 0.860 |
Why?
|
Tropoelastin | 1 | 2022 | 13 | 0.840 |
Why?
|
Biomimetics | 1 | 2022 | 10 | 0.840 |
Why?
|
Heart Ventricles | 2 | 2014 | 110 | 0.830 |
Why?
|
Biocompatible Materials | 2 | 2020 | 76 | 0.780 |
Why?
|
Pseudomonas aeruginosa | 1 | 2020 | 57 | 0.730 |
Why?
|
Choline | 1 | 2020 | 59 | 0.730 |
Why?
|
Anti-Infective Agents | 1 | 2020 | 64 | 0.720 |
Why?
|
Tissue Engineering | 5 | 2022 | 60 | 0.700 |
Why?
|
Cell Movement | 3 | 2019 | 571 | 0.690 |
Why?
|
Cytological Techniques | 1 | 2019 | 15 | 0.670 |
Why?
|
Ventricular Function, Left | 3 | 2013 | 96 | 0.560 |
Why?
|
Myocardial Ischemia | 2 | 2013 | 75 | 0.480 |
Why?
|
Myocardial Infarction | 3 | 2011 | 225 | 0.470 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 173 | 0.460 |
Why?
|
Skin Physiological Phenomena | 1 | 2013 | 11 | 0.450 |
Why?
|
Oxygen | 1 | 2013 | 207 | 0.410 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 19 | 0.390 |
Why?
|
Macrophage Activation | 1 | 2011 | 56 | 0.380 |
Why?
|
Gene Expression | 1 | 2013 | 674 | 0.360 |
Why?
|
Neovascularization, Physiologic | 3 | 2013 | 73 | 0.340 |
Why?
|
Rats, Sprague-Dawley | 7 | 2014 | 1618 | 0.310 |
Why?
|
Administration, Cutaneous | 2 | 2020 | 43 | 0.300 |
Why?
|
Macrophages | 1 | 2011 | 439 | 0.300 |
Why?
|
Animals | 11 | 2024 | 15081 | 0.290 |
Why?
|
Rats | 8 | 2014 | 3483 | 0.270 |
Why?
|
Mice | 4 | 2024 | 5913 | 0.260 |
Why?
|
Implants, Experimental | 1 | 2002 | 5 | 0.220 |
Why?
|
Polytetrafluoroethylene | 1 | 2002 | 6 | 0.220 |
Why?
|
Pericardium | 1 | 2002 | 15 | 0.210 |
Why?
|
Materials Testing | 1 | 2002 | 69 | 0.210 |
Why?
|
Collagen | 1 | 2022 | 172 | 0.190 |
Why?
|
Bandages | 1 | 2020 | 5 | 0.190 |
Why?
|
Cross-Linking Reagents | 1 | 2020 | 51 | 0.190 |
Why?
|
Ionic Liquids | 1 | 2020 | 16 | 0.190 |
Why?
|
Microbial Sensitivity Tests | 1 | 2020 | 201 | 0.180 |
Why?
|
Male | 6 | 2024 | 20025 | 0.170 |
Why?
|
Heart Failure | 2 | 2013 | 235 | 0.170 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 1609 | 0.170 |
Why?
|
Biofilms | 1 | 2020 | 168 | 0.160 |
Why?
|
Echocardiography | 4 | 2013 | 144 | 0.160 |
Why?
|
Humans | 5 | 2022 | 37093 | 0.150 |
Why?
|
Hemodynamics | 3 | 2013 | 91 | 0.140 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2014 | 8 | 0.130 |
Why?
|
Fibrinogen | 1 | 2014 | 23 | 0.120 |
Why?
|
Gelatin | 1 | 2014 | 15 | 0.120 |
Why?
|
Microscopy | 1 | 2014 | 32 | 0.120 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2013 | 10 | 0.120 |
Why?
|
Inflammation | 2 | 2013 | 618 | 0.120 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2014 | 86 | 0.120 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2013 | 4 | 0.110 |
Why?
|
Aquaporin 3 | 1 | 2013 | 3 | 0.110 |
Why?
|
Intermediate Filament Proteins | 1 | 2013 | 13 | 0.110 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2013 | 22 | 0.110 |
Why?
|
Interleukin-1 | 1 | 2013 | 35 | 0.110 |
Why?
|
Single-Blind Method | 1 | 2013 | 55 | 0.110 |
Why?
|
Collagen Type I | 1 | 2013 | 30 | 0.110 |
Why?
|
Deoxyguanosine | 1 | 2013 | 35 | 0.110 |
Why?
|
Elastin | 1 | 2013 | 40 | 0.110 |
Why?
|
Coronary Circulation | 2 | 2010 | 27 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2013 | 153 | 0.110 |
Why?
|
Myocytes, Cardiac | 1 | 2013 | 166 | 0.100 |
Why?
|
Algorithms | 1 | 2014 | 465 | 0.100 |
Why?
|
Cells, Cultured | 2 | 2014 | 1518 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 356 | 0.100 |
Why?
|
Mice, SCID | 1 | 2011 | 150 | 0.100 |
Why?
|
Cell Count | 1 | 2011 | 135 | 0.090 |
Why?
|
Dogs | 1 | 2011 | 149 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2011 | 57 | 0.090 |
Why?
|
Coronary Vessels | 1 | 2011 | 85 | 0.090 |
Why?
|
Female | 2 | 2024 | 20969 | 0.090 |
Why?
|
Disease Models, Animal | 2 | 2013 | 1371 | 0.090 |
Why?
|
Prosthesis Implantation | 1 | 2009 | 17 | 0.080 |
Why?
|
Extracellular Matrix | 1 | 2009 | 115 | 0.080 |
Why?
|
Adipose Tissue | 2 | 2002 | 177 | 0.060 |
Why?
|
Microcirculation | 1 | 2002 | 37 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2002 | 15 | 0.050 |
Why?
|
Aged | 1 | 2013 | 6741 | 0.050 |
Why?
|
Polymers | 1 | 2002 | 121 | 0.050 |
Why?
|
Middle Aged | 1 | 2013 | 10129 | 0.040 |
Why?
|
Sus scrofa | 1 | 2014 | 19 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2014 | 69 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2014 | 76 | 0.030 |
Why?
|
Actins | 1 | 2014 | 148 | 0.030 |
Why?
|
Stroke Volume | 1 | 2013 | 89 | 0.030 |
Why?
|
Cattle | 1 | 2014 | 477 | 0.030 |
Why?
|
Cell Communication | 1 | 2013 | 97 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2013 | 587 | 0.020 |
Why?
|
Captopril | 1 | 2009 | 8 | 0.020 |
Why?
|
Factor VIII | 1 | 2009 | 11 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2009 | 40 | 0.020 |
Why?
|
Systole | 1 | 2009 | 61 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2014 | 1198 | 0.020 |
Why?
|
Acute Disease | 1 | 2009 | 147 | 0.020 |
Why?
|
Cytokines | 1 | 2010 | 602 | 0.020 |
Why?
|
Blood Pressure | 1 | 2009 | 646 | 0.020 |
Why?
|
Blood Vessels | 1 | 2002 | 34 | 0.010 |
Why?
|